Morgan Wallen Makes History As He Refuses To Give Up The No. 1 Spot

ForbesMonday, October 13, 2025 at 12:00:00 PM
Morgan Wallen Makes History As He Refuses To Give Up The No. 1 Spot
Morgan Wallen has made history by keeping his duet 'What I Want' with Tate McRae at No. 1 for an impressive 20 weeks. This achievement marks him as the first solo artist to hold the top spot for such a lengthy period twice. This milestone not only highlights Wallen's popularity but also showcases the enduring appeal of his music in today's competitive industry.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Tate McRae Almost Scores Her First Solo No. 1 — What Song Stops Her?
PositiveFinancial Markets
Tate McRae is making waves in the music industry with her new single 'Tit for Tat,' which has debuted at No. 2 on Billboard’s Streaming Songs chart. This marks her highest solo debut yet, bringing her closer than ever to achieving her first No. 1 hit. This is significant not only for McRae's career but also for her growing fanbase, as it showcases her rising popularity and talent in a competitive music landscape.
Latest from Financial Markets
Apple TV Subtracts the + in a Quiet Rebrand
NeutralFinancial Markets
Apple has decided to drop the '+' from its Apple TV branding, signaling a subtle rebranding effort. This change reflects the company's strategy to streamline its services and focus on enhancing user experience. As the streaming landscape becomes increasingly competitive, this move could help Apple clarify its offerings and strengthen its position in the market.
TD Cowen lowers Beyond Meat stock price target to $0.80 on dilution
NegativeFinancial Markets
TD Cowen has lowered its price target for Beyond Meat's stock to $0.80, citing concerns over dilution. This significant reduction reflects ongoing challenges for the plant-based meat company, which has struggled to maintain investor confidence amid increasing competition and market pressures. The adjustment in the stock price target is a critical indicator of the company's financial health and could influence investor decisions moving forward.
Erste Group initiates coverage on Ecolab stock with Buy rating
PositiveFinancial Markets
Erste Group has started coverage on Ecolab stock, giving it a 'Buy' rating. This is significant as it reflects confidence in Ecolab's business model and growth potential, which could attract more investors and positively impact the stock's performance.
Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results
PositiveFinancial Markets
Erste Group has upgraded its rating for Eli Lilly to 'Buy' following the company's impressive first half results. This upgrade reflects confidence in Eli Lilly's strong performance and growth potential, which is significant for investors looking for promising stocks in the pharmaceutical sector.
Erste Group downgrades AbbVie stock rating to Hold on guidance cut
NegativeFinancial Markets
Erste Group has downgraded AbbVie's stock rating to 'Hold' following a cut in the company's guidance. This decision reflects concerns about AbbVie's future performance and could impact investor confidence. Such downgrades often lead to fluctuations in stock prices, making it crucial for investors to stay informed about the company's outlook.
Financial Services Roundup: Market Talk
NeutralFinancial Markets
The latest Market Talks provide valuable insights into the financial services sector, focusing on key developments such as the London Stock Exchange Group's performance, the third quarter results of Chinese banks, and updates from Blackstone. These insights are crucial for investors and analysts as they navigate the complexities of the market.